Stay updated on TAK-861 Study in Narcolepsy Type 2 Clinical Trial

Sign up to get notified when there's something new on the TAK-861 Study in Narcolepsy Type 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAK-861 Study in Narcolepsy Type 2 Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Results have been posted for NCT05687916 (Results First Posted 2025-01-09), and the study record now shows updated enrollment and completion data along with the outcomes reporting dates.
    Difference
    0.3%
    Check dated 2025-10-30T07:34:29.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    35 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-30T05:25:33.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Removed MedlinePlus Drug Safety topic and related MeSH terms (Substandard Drugs, Pharmaceutical Preparations, Counterfeit Drugs); overall topic scope is narrowed. No new content added.
    Difference
    0.5%
    Check dated 2025-09-23T03:10:23.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Page updated from revision v3.0.1 to v3.0.2; the old Back to Top control was removed. There are no visible changes to core content or critical data.
    Difference
    0.2%
    Check dated 2025-09-14T23:37:53.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.2%
    Check dated 2025-09-07T20:17:55.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has added several new facility names and locations, including specific cities in Japan, the Netherlands, Spain, and Sweden, while removing some previously listed locations and related resources. Additionally, new topics related to drug safety have been introduced.
    Difference
    3%
    Check dated 2025-08-31T12:53:21.000Z thumbnail image

Stay in the know with updates to TAK-861 Study in Narcolepsy Type 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAK-861 Study in Narcolepsy Type 2 Clinical Trial page.